SPOTLIGHT: Internal controls will be a necessity of meaningful use compliance

When you hear the term 'internal controls,' you may think of them in terms of the financial industry's Sarbanes-Oxley (SOX) compliance. However, internal controls have also manifested within the healthcare and life sciences industries, as Hospital Impact contributor Joe Ingemi points out. Hospital Impact

Suggested Articles

Roche, which already owned a 12.6% stake in Flatiron Health, has agreed to buy the health IT company for $1.9 billion.

Allscripts managed to acquire two EHR platforms for just $50 million by selling off a portion of McKesson's portfolio for as much as $235 million.

Artificial intelligence could help physicians predict a patient's risk of developing a deadly infection.